New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Breast Cancer Registrations Hit All-Time High in Bengaluru Hospitals

Breast Cancer Registrations Hit All-Time High in Bengaluru Hospitals

byColleen Fleisson October 16, 2023 at 11:51 PMBreast Cancer Awareness Month, occurring every October, aims to raise awareness about this lethal disease. In Bengaluru, Karnataka, breast ca
World medicine December 05,2023
Breast Cancer Registrations Hit All-Time High in Bengaluru Hospitals

Breast Cancer Registrations Hit All-Time High in Bengaluru Hospitals

byColleen Fleisson October 16, 2023 at 11:51 PMBreast Cancer Awareness Month, occurring every October, aims to raise awareness about this lethal disease. In Bengaluru, Karnataka, breast ca
World medicine December 05,2023
AstraZeneca's Tagrisso Drug to Rule Lung Cancer Small Molecule Market

AstraZeneca's Tagrisso Drug to Rule Lung Cancer Small Molecule Market

byColleen Fleisson October 14, 2023 at 4:13 PMTagrisso, a brand-name medication, the commercial name forOsimertinib, is positioned to become a cornerstone of AstraZeneca's portfo
World medicine December 05,2023
AstraZeneca's Tagrisso Drug to Rule Lung Cancer Small Molecule Market

AstraZeneca's Tagrisso Drug to Rule Lung Cancer Small Molecule Market

byColleen Fleisson October 14, 2023 at 4:13 PMTagrisso, a brand-name medication, the commercial name forOsimertinib, is positioned to become a cornerstone of AstraZeneca's portfo
World medicine December 05,2023
Significant disparities in breast cancer care persist, but surgeons can drive change

Significant disparities in breast cancer care persist, but surgeons can drive change

byAmerican College of SurgeonsThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI Center for Cance
World medicine December 04,2023
Significant disparities in breast cancer care persist, but surgeons can drive change

Significant disparities in breast cancer care persist, but surgeons can drive change

byAmerican College of SurgeonsThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI Center for Cance
World medicine December 04,2023
ENZAMET shows promise as prostate cancer treatment

ENZAMET shows promise as prostate cancer treatment

byUniversity of AdelaideMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0A new drug combination for men with advan
World medicine December 04,2023
ENZAMET shows promise as prostate cancer treatment

ENZAMET shows promise as prostate cancer treatment

byUniversity of AdelaideMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0A new drug combination for men with advan
World medicine December 04,2023
Researchers design a microfluidics physics-based device to predict cancer therapy response

Researchers design a microfluidics physics-based device to predict cancer therapy response

byUniversity of BarcelonaMicrofluidic dynamic BH3 profiling platform.aSchematic representation of the chip including exploded view of all the parts: (i) lower glass slide, (ii) thin
World medicine December 04,2023
Researchers design a microfluidics physics-based device to predict cancer therapy response

Researchers design a microfluidics physics-based device to predict cancer therapy response

byUniversity of BarcelonaMicrofluidic dynamic BH3 profiling platform.aSchematic representation of the chip including exploded view of all the parts: (i) lower glass slide, (ii) thin
World medicine December 04,2023
A targeted method to combat cancer

A targeted method to combat cancer

by Marita Fuchs,University of ZurichCancer tissue visualized in 3D: the cells involved in a tumor can be differentiated using a unique method. Credit: Marc LatzelBy analyzing tumors in unprecede
World medicine December 04,2023
A targeted method to combat cancer

A targeted method to combat cancer

by Marita Fuchs,University of ZurichCancer tissue visualized in 3D: the cells involved in a tumor can be differentiated using a unique method. Credit: Marc LatzelBy analyzing tumors in unprecede
World medicine December 04,2023
International panel classifies immunotherapy side effects for the first time

International panel classifies immunotherapy side effects for the first time

by RCSIConsensus definitions for irAE terminology. ICI, immune checkpoint inhibitor; IO, immuno-oncology; irAE, immune-related adverse event. Credit:Journal for ImmunoTherapy of Cancer(202
World medicine December 04,2023
International panel classifies immunotherapy side effects for the first time

International panel classifies immunotherapy side effects for the first time

by RCSIConsensus definitions for irAE terminology. ICI, immune checkpoint inhibitor; IO, immuno-oncology; irAE, immune-related adverse event. Credit:Journal for ImmunoTherapy of Cancer(202
World medicine December 04,2023
More US prostate cancer patients choosing active surveillance over surgery or radiation

More US prostate cancer patients choosing active surveillance over surgery or radiation

byVanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainThe number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly incre
World medicine December 04,2023
More US prostate cancer patients choosing active surveillance over surgery or radiation

More US prostate cancer patients choosing active surveillance over surgery or radiation

byVanderbilt University Medical CenterCredit: Pixabay/CC0 Public DomainThe number of prostate cancer patients in the U.S. choosing active surveillance over surgery or radiation has rapidly incre
World medicine December 04,2023
Study establishes link between wound fibroblasts and cancer-associated fibroblasts

Study establishes link between wound fibroblasts and cancer-associated fibroblasts

byETH ZurichConceptual summary: During wound healing, sequential healing phases return the injured tissue to homeostasis. As a "wound that fails to heal", cancer stalls in the early ph
World medicine December 04,2023
Study establishes link between wound fibroblasts and cancer-associated fibroblasts

Study establishes link between wound fibroblasts and cancer-associated fibroblasts

byETH ZurichConceptual summary: During wound healing, sequential healing phases return the injured tissue to homeostasis. As a "wound that fails to heal", cancer stalls in the early ph
World medicine December 04,2023
Tool targets cancer-causing fusions' weak spot

Tool targets cancer-causing fusions' weak spot

bySt. Jude Children's Research HospitalModel of fusion etiology and study design.aTheoretical mechanisms of oncogenic fusion formation. Scenario 1: the DNA breakpoints (red lines
World medicine December 04,2023
Tool targets cancer-causing fusions' weak spot

Tool targets cancer-causing fusions' weak spot

bySt. Jude Children's Research HospitalModel of fusion etiology and study design.aTheoretical mechanisms of oncogenic fusion formation. Scenario 1: the DNA breakpoints (red lines
World medicine December 04,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com